Alzamend Neuro Inc
ALZN | NASDAQ
$1.94
+$0.05 (+2.65%)
At close: Sep 21, 2026, 4:00 PM ET
$1.93
-$0.01 (-0.52%)
After-hours:
Sep 21, 2026, 7:30 PM ET
TTM Period Ending | Q1 2027 Jul 30, 2026 | Q4 2026 Apr 29, 2026 | Q3 2026 Jan 30, 2026 | Q2 2026 Oct 30, 2025 | Q1 2026 Jul 30, 2025 | Q4 2025 Apr 29, 2025 | Q3 2025 Jan 30, 2025 | Q2 2025 Oct 30, 2024 | Q1 2025 Jul 30, 2024 | Q4 2024 Apr 29, 2024 | Q3 2024 Jan 30, 2024 | Q2 2024 Oct 30, 2023 | Q1 2024 Jul 30, 2023 | Q4 2023 Apr 29, 2023 | Q3 2023 Jan 30, 2023 | Q2 2023 Oct 30, 2022 | Q1 2023 Jul 30, 2022 | Q4 2022 Apr 29, 2022 | Q3 2022 Jan 30, 2022 | Q2 2022 Oct 30, 2021 | Q1 2022 Jul 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 7.59M | 710.69K | 2.71M | 4.45M | 5.62M | 3.95M | 3.36M | 4.09M | 1.19M | 376.05K | 282.87K | 200.08K | 1.7M | 5.14M | 7.38M | 9.18M | 11.53M | 14.06M | 11.79M | 13.57M | 15.62M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 70K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | 0 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.41K | n/a | n/a | 16.21K | 16.21K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | 1.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 8.25M | 1.76M | 3.7M | 4.72M | 5.93M | 4.18M | 3.95M | 4.77M | 1.42M | 455.24K | 593.61K | 781.88K | 2.41M | 5.84M | 8.42M | 10.33M | 12.11M | 14.41M | 12.43M | 14.5M | 16.82M |
Property-Plant & Equipment | 287.18K | 314.87K | 342.55K | 370.24K | 397.92K | 425.61K | 228.29K | 240.98K | 253.66K | 176.35K | 189.03K | 201.72K | 214.4K | 79.84K | 85.17K | 90.49K | 95.81K | 102.91K | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 287.18K | 314.87K | 342.55K | 370.24K | 397.92K | 425.61K | 228.29K | 240.98K | 253.66K | 176.35K | 259.03K | 201.72K | 214.4K | 79.84K | 85.17K | 90.49K | 95.81K | 102.91K | n/a | n/a | n/a |
Total Assets | 8.54M | 2.08M | 4.04M | 5.09M | 6.33M | 4.6M | 4.18M | 5.01M | 1.67M | 631.59K | 852.64K | 983.6K | 2.63M | 5.92M | 8.5M | 10.42M | 12.21M | 14.52M | 12.43M | 14.5M | 16.82M |
Account Payables | 2.74M | 1.35M | 1.86M | 717.49K | 983.31K | 634.76K | 725.85K | 1.25M | 2.88M | 2.93M | 3.83M | 3.67M | 2.74M | 2.87M | 2.64M | 648.12K | 1.03M | 1.16M | 464.9K | 1.13M | 1.07M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 300.71K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 344.89K | 340.1K |
Other Current Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 989.33K | n/a | n/a | 2.08K | 2.18K | n/a |
Total Current Liabilities | 2.74M | 1.35M | 1.86M | 717.49K | 983.31K | 634.76K | 725.85K | 1.25M | 2.88M | 3.23M | 3.83M | 3.67M | 2.74M | 2.87M | 2.64M | 1.64M | 1.03M | 1.16M | 466.98K | 1.48M | 1.47M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 477.74K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | 742.26K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | 1.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Liabilities | 2.74M | 1.35M | 1.86M | 717.49K | 983.31K | 634.76K | 725.85K | 1.25M | 2.88M | 3.23M | 5.05M | 3.67M | 2.74M | 2.87M | 2.64M | 1.64M | 1.03M | 1.16M | 466.98K | 1.48M | 1.47M |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 300.71K | 477.74K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 344.89K | 340.1K |
Book Value | 5.8M | 733.21K | 2.18M | 4.37M | 5.34M | 3.97M | 3.45M | 3.75M | -1.21M | -2.59M | -4.19M | -2.68M | -112.88K | 3.05M | 5.86M | 8.79M | 11.18M | 13.35M | 11.96M | 13.03M | 15.34M |
Book Value Per Share | 1.30 | 0.22 | 0.57 | 1.29 | 2.54 | 5.58 | 5.63 | 9.56 | -14.21 | -33.93 | -53.51 | -36.78 | -1.55 | 42.48 | 80.45 | 121.69 | 154.85 | 204.99 | 171.50 | 188.15 | 244.89 |
Common Stock | 482 | 425 | 380 | 380 | 314 | 78 | 580 | 523 | 86 | 69 | 662 | 647 | 9.69K | 9.69K | 9.64K | 9.55K | 9.55K | 9.55K | 9.01K | 8.89K | 8.69K |
Retained Earnings | -70.33M | -67.31M | -64.44M | -62.24M | -61.24M | -58.54M | -57.4M | -56.41M | -54.99M | -54.02M | -53.17M | -50.51M | -47.6M | -44.07M | -40.77M | -35.34M | -32.23M | -29.19M | -25.33M | -22.75M | -19.15M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -14.88M | -14.88M | -14.88M | n/a | -14.88M | -14.88M | -14.88M | -14.88M | -14.88M | -14.88M |
Shareholders Equity | 5.8M | 733.21K | 2.18M | 4.37M | 5.34M | 3.97M | 3.45M | 3.75M | -1.21M | -2.59M | -4.19M | -2.68M | -112.88K | 3.05M | 5.86M | 8.79M | 11.18M | 13.35M | 11.96M | 13.03M | 15.34M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 70K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ALZN